Furthermore, using smart insulin pen devices in conjunction with CGM could enable the timely detection of missed basal insulin injections, improving the quality of discussions between HCPs and patients, thereby increasing patient awareness, empowering patients to improve their diabetes management, and providing ongoing diabetes management education and support. The gene discussed is INS; the disease is diabetes mellitus.